Evidence map›Paper›PMID 32682477›Full record

ArticleLancet (London, England)2020

Tranexamic acid for traumatic brain injury.

Angelos G Kolias, Daniel Horner, David K Menon, Mark Wilson, Peter J Hutchinson

Open access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Angelos G KoliasDivision of Neurosurgery, Department of Clinical Neurosciences, and Division of Anaesthesia and Neurosciences Critical Care Unit, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 0QQ, UK. Electronic address: ak721@cam.ac.uk.
Daniel HornerEmergency Department, Salford Royal NHS Foundation Trust, Salford, UK; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester, UK; The Royal College of Emergency Medicine, London, UK.
David K MenonDivision of Neurosurgery, Department of Clinical Neurosciences, and Division of Anaesthesia and Neurosciences Critical Care Unit, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 0QQ, UK.
Mark WilsonImperial Neurotrauma Centre, Department of Surgery & Cancer, Imperial College London, London, UK.
Peter J HutchinsonDivision of Neurosurgery, Department of Clinical Neurosciences, and Division of Anaesthesia and Neurosciences Critical Care Unit, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 0QQ, UK.
University of Cambridge · GBAddenbrooke's Hospital · GBImperial College London · GBRoyal College of Emergency Medicine · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifibrinolytic AgentsBrain InjuriesBrain Injuries, TraumaticVascular DiseasesHumansTranexamic AcidAntifibrinolytic AgentsTranexamic Acid

Identifiers

PMID32682477
OpenAlexW3042564698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.